Polen Capital Management
ROIV icon

Polen Capital Management’s Roivant Sciences ROIV Stock Holding History

Polen Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306K Buy
+8,659
New +$256K ﹤0.01% 205
2026
Q1 		– Sell
-9,662
Closed -$210K – 280
2025
Q4 		$210K Buy
+9,662
New +$191K ﹤0.01% 228

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Polen Capital Management's ROIV Position: Q2 2026 in Review

Polen Capital Management opened a new position in Roivant Sciences (ROIV) in Q2 2026: 8,659 shares worth $306K. The stake represents ﹤0.01% of the portfolio and ranks #205 among its holdings. This is a return to the name: Polen Capital Management previously reported a position in ROIV as recently as Q4 2025.

Polen Capital Management first reported a position in ROIV in Q4 2025 and has held it in 2 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Polen Capital Management held 8,659 shares of Roivant Sciences worth $306K as of Q2 2026.
  • Roivant Sciences was a new Polen Capital Management position in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of Polen Capital Management's portfolio in Q2 2026, its #205 holding.
  • Polen Capital Management first reported a position in Roivant Sciences in Q4 2025 and has held it in 2 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Polen Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.